Copenhagen, Denmark

Anne Louise Kjolbye

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Zealand Pharma A/s. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Louise Kjolbye. Retrieved from https://idiyas.com/inventor/anne-louise-kjolbye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 22(Granted Patents)


Location History:

  • Hellebaek, DK (2009)
  • Copenhagen, DK (2010)

Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anne Louise Kjolbye: Innovator in Antiarrhythmic Peptides

Introduction

Anne Louise Kjolbye is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of medicinal peptides, particularly focusing on antiarrhythmic compounds. With a total of 2 patents, her work has the potential to impact medical treatments significantly.

Latest Patents

Kjolbye's latest patents include innovative peptides that exhibit antiarrhythmic properties. These peptides are noted for their improved stability, which enhances their effectiveness as medicaments. Additionally, she has disclosed compositions that incorporate these peptides, along with methods for their use in medical applications. Her research also covers intercellular communication facilitating compounds, further emphasizing her commitment to advancing medical science.

Career Highlights

Anne Louise Kjolbye is associated with Zealand Pharma A/S, where she continues to develop her groundbreaking work. Her career is marked by a dedication to improving therapeutic options for patients suffering from arrhythmias and other related conditions.

Collaborations

Kjolbye has collaborated with notable colleagues, including Bjarne Due Larsen and Eddi Meier. These partnerships have fostered a collaborative environment that enhances the innovation process within her field.

Conclusion

Anne Louise Kjolbye stands out as a leading inventor in the realm of antiarrhythmic peptides, with her work promising to advance medical treatments significantly. Her contributions reflect a deep commitment to improving patient care through innovative research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…